Analysis of rodent growth data in toxicology studies.

Autor: Hoffman WP; Statistics and Information Sciences, Lilly Research Laboratories, Eli Lilly and Company, Drop Code GL43, 2001 West Main Street, Greenfield, Indiana 46140, USA. hoffman_wherly_p@lilly.com, Ness DK, van Lier RB

Publikováno v: Toxicological sciences : an official journal of the Society of Toxicology [Toxicol Sci] 2002 Apr; Vol. 66 (2), pp. 313-9.

Stereoselective disposition of the enantiomers of the benzoquinolinone LY191704, a human type I 5 alpha-reductase inhibitor. Differences between rats and dogs.

Autor: Farid NA; Division of Drug Metabolism and Disposition, Lilly Research Laboratories, Indianapolis, IN 46285, USA., Schreiner KM, Coleman NL, Van Lier RB, Wrighton SA

Publikováno v: Drug metabolism and disposition: the biological fate of chemicals [Drug Metab Dispos] 1996 Oct; Vol. 24 (10), pp. 1162-5.

Effects of chronic treatment with the leukotriene D4-antagonist compound LY171883 on B6C3F1 mice.

Autor: Bendele AM; Toxicology Division, Lilly Research Laboratories, Eli Lilly and Company, Greenfield, Indiana 46140., Hoover DM, van Lier RB, Foxworthy PS, Eacho PI

Publikováno v: Fundamental and applied toxicology : official journal of the Society of Toxicology [Fundam Appl Toxicol] 1990 Nov; Vol. 15 (4), pp. 676-82.

Metabolism of 7-ethoxyresorufin by phenobarbital or Aroclor 1254 pretreated mice.

Autor: Glass SJ; Department of Biochemical Toxicology, Lilly Research Laboratories, Greenfield, IN 46140., van Lier RB

Publikováno v: Drug metabolism and disposition: the biological fate of chemicals [Drug Metab Dispos] 1988 Mar-Apr; Vol. 16 (2), pp. 333-4.

Isolation of a factor that protects against lead inhibition of hepatic and erythrocytic uroporphyrinogen I synthetase activity.

Autor: Piper WN, Van Lier RB

Publikováno v: Life sciences [Life Sci] 1976 Oct 15; Vol. 19 (8), pp. 1225-34.